JPY 1448.0
(0.49%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 5.32 Billion JPY | 12.68% |
2022 | 4.72 Billion JPY | 20.12% |
2021 | 3.93 Billion JPY | -35.86% |
2020 | 6.13 Billion JPY | -0.31% |
2019 | 6.14 Billion JPY | -10.48% |
2018 | 6.86 Billion JPY | 4.49% |
2017 | 6.57 Billion JPY | -10.01% |
2016 | 7.3 Billion JPY | -46.44% |
2015 | 13.63 Billion JPY | 13.06% |
2014 | 12.06 Billion JPY | 0.32% |
2013 | 12.02 Billion JPY | -3.2% |
2012 | 12.42 Billion JPY | 34.57% |
2011 | 9.23 Billion JPY | -15.52% |
2010 | 10.92 Billion JPY | 23.5% |
2009 | 8.84 Billion JPY | 334.36% |
2008 | 2.03 Billion JPY | -6.94% |
2007 | 2.18 Billion JPY | -54.79% |
2006 | 4.84 Billion JPY | -7.38% |
2005 | 5.22 Billion JPY | 159.71% |
2004 | 2.01 Billion JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 885 Million JPY | -37.14% |
2023 Q1 | 676 Million JPY | 95.38% |
2023 Q4 | 1.4 Billion JPY | -34.72% |
2023 FY | 5.32 Billion JPY | 12.68% |
2023 Q3 | 2.15 Billion JPY | 99.54% |
2023 Q2 | 1.08 Billion JPY | 59.91% |
2022 Q3 | 3.13 Billion JPY | 5213.56% |
2022 Q4 | 346 Million JPY | -88.96% |
2022 Q1 | 1.18 Billion JPY | -18.36% |
2022 Q2 | 59 Million JPY | -95.01% |
2022 FY | 4.72 Billion JPY | 20.12% |
2021 Q2 | 583 Million JPY | 226.19% |
2021 FY | 3.93 Billion JPY | -35.86% |
2021 Q3 | 2.36 Billion JPY | 305.15% |
2021 Q4 | 1.44 Billion JPY | -38.65% |
2021 Q1 | -462 Million JPY | -128.41% |
2020 Q1 | 1.6 Billion JPY | -9.35% |
2020 Q4 | 1.62 Billion JPY | -31.85% |
2020 Q2 | 509 Million JPY | -68.37% |
2020 Q3 | 2.38 Billion JPY | 368.76% |
2020 FY | 6.13 Billion JPY | -0.31% |
2019 Q4 | 1.77 Billion JPY | -49.86% |
2019 Q1 | 1.28 Billion JPY | -27.15% |
2019 Q2 | -446 Million JPY | -134.84% |
2019 Q3 | 3.54 Billion JPY | 893.72% |
2019 FY | 6.14 Billion JPY | -10.48% |
2018 Q1 | 1.07 Billion JPY | 136.7% |
2018 Q4 | 1.75 Billion JPY | -39.31% |
2018 Q2 | 1.14 Billion JPY | 5.85% |
2018 Q3 | 2.89 Billion JPY | 153.95% |
2018 FY | 6.86 Billion JPY | 4.49% |
2017 Q1 | 2.39 Billion JPY | -7.32% |
2017 Q4 | 455 Million JPY | -90.67% |
2017 Q3 | 4.87 Billion JPY | 523.16% |
2017 Q2 | -1.15 Billion JPY | -148.18% |
2017 FY | 6.57 Billion JPY | -10.01% |
2016 Q1 | 2.58 Billion JPY | -8.12% |
2016 FY | 7.3 Billion JPY | -46.44% |
2016 Q3 | 2.03 Billion JPY | 1860.58% |
2016 Q4 | 2.58 Billion JPY | 26.63% |
2016 Q2 | 104 Million JPY | -95.97% |
2015 FY | 13.63 Billion JPY | 13.06% |
2015 Q3 | 7.86 Billion JPY | 549.92% |
2015 Q2 | 1.21 Billion JPY | -31.13% |
2015 Q1 | 1.75 Billion JPY | -29.52% |
2015 Q4 | 2.8 Billion JPY | -64.29% |
2014 FY | 12.06 Billion JPY | 0.32% |
2014 Q2 | 814 Million JPY | -69.64% |
2014 Q3 | 6.07 Billion JPY | 646.44% |
2014 Q4 | 2.49 Billion JPY | -58.97% |
2014 Q1 | 2.68 Billion JPY | -2.62% |
2013 Q3 | 4.87 Billion JPY | 247.97% |
2013 Q4 | 2.75 Billion JPY | -43.53% |
2013 Q2 | 1.4 Billion JPY | -53.24% |
2013 Q1 | 2.99 Billion JPY | -5.19% |
2013 FY | 12.02 Billion JPY | -3.2% |
2012 Q1 | 2.83 Billion JPY | 41.62% |
2012 FY | 12.42 Billion JPY | 34.57% |
2012 Q4 | 3.16 Billion JPY | -36.38% |
2012 Q3 | 4.96 Billion JPY | 240.91% |
2012 Q2 | 1.45 Billion JPY | -48.66% |
2011 FY | 9.23 Billion JPY | -15.52% |
2011 Q2 | 658 Million JPY | -75.6% |
2011 Q3 | 3.87 Billion JPY | 488.45% |
2011 Q4 | 2 Billion JPY | -48.24% |
2011 Q1 | 2.69 Billion JPY | -20.49% |
2010 Q2 | 1.16 Billion JPY | -35.52% |
2010 Q1 | 1.79 Billion JPY | 37.22% |
2010 FY | 10.92 Billion JPY | 23.5% |
2010 Q4 | 3.39 Billion JPY | -25.87% |
2010 Q3 | 4.57 Billion JPY | 294.48% |
2009 FY | 8.84 Billion JPY | 334.36% |
2009 Q2 | 1.31 Billion JPY | -33.4% |
2009 Q3 | 4.24 Billion JPY | 222.49% |
2009 Q4 | 1.31 Billion JPY | -69.11% |
2009 Q1 | 1.97 Billion JPY | 65.36% |
2008 FY | 2.03 Billion JPY | -6.94% |
2008 Q3 | 2.44 Billion JPY | 214.07% |
2008 Q4 | 1.19 Billion JPY | -51.2% |
2008 Q2 | -2.14 Billion JPY | 0.0% |
2007 FY | 2.18 Billion JPY | -54.79% |
2006 FY | 4.84 Billion JPY | -7.38% |
2005 FY | 5.22 Billion JPY | 159.71% |
2004 FY | 2.01 Billion JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -66.053% |
Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 96.306% |
Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 101.69% |
Shionogi & Co., Ltd. | 162.03 Billion JPY | 96.715% |
Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -4784.406% |
Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 79.413% |
Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 33.682% |
Eisai Co., Ltd. | 42.4 Billion JPY | 87.45% |
Morishita Jintan Co., Ltd. | 697 Million JPY | -663.558% |
Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 61.901% |
Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -17.044% |
Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -286.492% |
Nippon Chemiphar Co., Ltd. | -180 Million JPY | 3056.667% |
Tsumura & Co. | 16.7 Billion JPY | 68.145% |
Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 52.312% |
Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -29.206% |
Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 67.093% |
Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -54.934% |
Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 31.163% |
Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 208.745% |
Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -61.517% |
SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 371.141% |
MedRx Co., Ltd | -932 Million JPY | 671.03% |
Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -41.009% |
Solasia Pharma K.K. | -1.11 Billion JPY | 578.597% |
Modalis Therapeutics Corporation | -2.39 Billion JPY | 322.508% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 29.463% |
Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 61.139% |
Cyfuse Biomedical K.K. | -589.21 Million JPY | 1003.242% |
Toho Holdings Co., Ltd. | 20.65 Billion JPY | 74.236% |
Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -80.631% |